Skip to main content
OpenTrials

Clinical trial condition

Congenital Hyperinsulinism

Explore clinical trials studying Congenital Hyperinsulinism. Study availability and eligibility vary by location and protocol.

29 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Congenital Hyperinsulinism trial results

Not yet recruiting

Umbilical Cord Glucose

NCT07795047

Conditions
Congenital Hyperinsulinism, Congenital Hyperinsulinism (CHI), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +8 more
Locations

Not specified

View Trial Details
Active, not recruiting

HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)

NCT04732416

Conditions
Congenital Hyperinsulinism, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +7 more
Locations
  • The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Otto-von-Guericke-Universitaet Magdeburg Magdeburg, Germany
  • Hadassah Medical Center (HMC) Jerusalem, Israel
  • Pusan National University Yangsan Hospital Pusan, South Korea
View Trial Details
Active, not recruiting

Early Check: Expanded Screening in Newborns

NCT03655223

Conditions
17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
Locations
  • RTI International Research Triangle Park, North Carolina, United States
View Trial Details
Active, not recruiting

RZ358 Treatment for Congenital Hyperinsulinism

NCT06208215

Conditions
Congenital Hyperinsulinism, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +7 more
Locations
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Cook Children's Medical Center Fort Worth, Texas, United States
  • Rezolute Investigative Site, Varna, Bulgaria Varna, Bulgaria
  • Rezolute Investigative Site, Odense, Denmark Odense, Denmark
View all 18 locations
View Trial Details
Completed

Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital Hyperinsulinism

NCT03941236

Conditions
Congenital Hyperinsulinism, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +7 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Cook Children's Endocrinology and Diabetes Clinic Fort Worth, Texas, United States
  • University Hospital Düsseldorf, Department of Pediatrics Düsseldorf, Germany
View Trial Details
Completed

Baby Detect : Genomic Newborn Screening

NCT05687474

Conditions
3-Hydroxy 3-Methyl Glutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency, +368 more
Locations
  • CRMN, Hôpital La Citadelle Liège, Wallonia, Belgium
View Trial Details

Related conditions